Coegin Pharma ABNGM: COEGIN

COEGIN: Strong R&D progress and partnerships, but future funding remains a key uncertainty

· Issued by Coegin Pharma AB

Coegin Pharma advanced its peptide-based hair growth and skin pigmentation projects, improved its financial position, and secured key partnerships, but faces material uncertainty regarding future financing beyond Q4 2025.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Coegin Pharma AB on 6ix

Earlier from Coegin Pharma

Later from Coegin Pharma

All Coegin Pharma news releases